Tolentino, Primo E.
HRN: 27-19-56 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2026
ACICLOVIR 800MG (TAB)
05/10/2026
05/17/2026
PO
800mg
Q6
Herpes Zoster
Checking Initial Appropriateness
05/10/2026
CLINDAMYCIN 300MG (CAP)
05/10/2026
05/17/2026
PO
300mg
Q6
HERPES ZOSTER
Checking Initial Appropriateness
05/10/2026
MUPIROCIN 2%, 15G (TUBE)
05/10/2026
05/17/2026
TOPICAL
15g
BID
Herpes Zoster
Checking Initial Appropriateness
05/10/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/10/2026
05/17/2026
IV
2g
Q8
Herpes Zoster
Checking Initial Appropriateness
05/10/2026
CLINDAMYCIN 300MG (CAP)
05/10/2026
05/17/2026
PO
600mg
Q6
Herpes Zoster
Checking Initial Appropriateness
05/10/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/10/2026
05/17/2026
IV
600mg
Q6
Herpes Zoster
Checking Initial Appropriateness
05/10/2026
ACICLOVIR 800MG (TAB)
05/10/2026
05/17/2026
PO
800mg
Q4
Herpes Zoster
Checking Initial Appropriateness
05/12/2026
CLINDAMYCIN 300MG (CAP)
05/12/2026
05/17/2026
PO
300mg
Q6
Herpes Zoster
Checking Initial Appropriateness